Protalix BioTherapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol: PLX on NYSE
Industry: Biological Products, (No Diagnostic Substances)
Location: 2 University Plaza, Suite 100, Hackensack, New Jersey

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+64.5K	100%	$1.40	+$90.5K
Sells	0
Net	+1	+64.5K	100%		+$90.5K

Protalix BioTherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Dexcel Pharma Technologies Ltd.	10%+ Owner	$5.13M			Jun 2, 2021
Dror Bashan	PRESIDENT AND CEO, Director	$3.03M	+$90.5K	+3.08%	Oct 19, 2023
Eyal Rubin	Sr. VP and CFO	$804K			Aug 15, 2023
Yaron Naos	Sr. VP, Operations	$293K			Aug 15, 2023
Yael Hayon	VP, Research & Development	$49.5K			Aug 15, 2023
Zeev Bronfeld	Director				Sep 7, 2022
Eliot Forster	Director				Sep 14, 2023
Aharon Schwartz	Director				Sep 29, 2023
Gwen A. Melincoff	Director				Sep 29, 2023
Zvi Shmuel Ben	Director				Sep 29, 2023
Pol F. Boudes	Director				Sep 29, 2023
Amos Bar-Shalev	Director				Sep 29, 2023

Recent Insider Transactions by Companies or Individuals for Protalix BioTherapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.